Geven, C., van Lier, D., Blet, A., Peelen, R., ten Elzen, B., Mebazaa, A., . . . Pickkers, P. (2018). Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first‐in‐human study and during experimental human endotoxaemia in healthy subjects. Br J Clin Pharmacol.
Styl cytowania ChicagoGeven, Christopher, Dirk van Lier, Alice Blet, Roel Peelen, Bas ten Elzen, Alexandre Mebazaa, Matthijs Kox, i Peter Pickkers. "Safety, Tolerability and Pharmacokinetics/pharmacodynamics of the Adrenomedullin Antibody Adrecizumab in a First‐in‐human Study and During Experimental Human Endotoxaemia in Healthy Subjects." Br J Clin Pharmacol 2018.
Styl cytowania MLAGeven, Christopher, et al. "Safety, Tolerability and Pharmacokinetics/pharmacodynamics of the Adrenomedullin Antibody Adrecizumab in a First‐in‐human Study and During Experimental Human Endotoxaemia in Healthy Subjects." Br J Clin Pharmacol 2018.